Clinical Trial Update: Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in Cornelia de Lange Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for N-acetylcysteine evaluating its effect on repetitive and self-injurious behaviors in individuals with Cornelia de Lange Synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cornelia De Lange Syndrome

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Cornelia de Lange Syndrome | Phase 2 | Status: NOT_YET_RECRUITING